openPR Logo
Press release

Evolving Market Trends In The Organoids And Spheroids Industry: Innovative Single-Particle Dispensers Drive Precision And Efficiency In Drug Discovery

05-29-2025 07:00 AM CET | Health & Medicine

Press release from: The Business Research Company

Organoids And Spheroids

Organoids And Spheroids

The Organoids And Spheroids Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Organoids And Spheroids Market Size During the Forecast Period?
The organoids and spheroids market has seen significant expansion in recent times. It is projected to increase from $1.16 billion in 2024 to $1.45 billion in 2025, reflecting a compound annual growth rate (CAGR) of 24.6%. This growth in earlier years was fueled by advancements in stem cell and 3D cell culture technologies, higher levels of funding and investment, a surge in chronic disease cases, growing utilization in drug testing and toxicology, as well as progress in regenerative and personalized medicine, alongside supportive regulatory policies.

The organoids and spheroids market is expected to experience rapid growth in the coming years. It will reach $3.46 billion by 2029, with a compound annual growth rate (CAGR) of 24.4%. This growth is due to ongoing technological advancements, the expansion of personalized medicine, broader applications in cancer research, evolving ethical and regulatory standards, an increase in commercial products and services utilizing organoid and spheroid technologies, and more educational programs to train researchers. Key trends include integrating advanced technologies, expanding high-throughput screening for drug discovery, the use of 3D bioprinting, growing use of organoids in cancer modeling, and combining organoids with microfluidic systems.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18421

What Are the High-Growth Segments in the Organoids And Spheroids Market?
The organoids and spheroids market covered in this report is segmented -

1) By Type: Organoids, Spheroids
2) By Method: Extracellular Matrix Scaffold Method, Spinning Bioreactor Method, Hanging Drop Method, Low Adherent Culture Plate Method, Magnetic levitation Method, Other Methods
3) By Application: Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, Drug Toxicity And Efficacy Testing
4) By End User: Biotechnology And Pharmaceutical Industry, Academic And Research Institutes, Hospitals And Diagnostic Centers

Subsegments:
1) By Organoids: Intestinal Organoids, Liver Organoids, Brain Organoids, Kidney Organoids, Lung Organoids, Pancreatic Organoids, Cardiac Organoids, Retinal Organoids, Tumor Organoids, Organoids For Disease Modeling
2) By Spheroids: Cancer Spheroids, Neural Spheroids, Cardiac Spheroids, Liver Spheroids, Muscle Spheroids, Endothelial Spheroids, Stem Cell-Derived Spheroids, 3D Cell Culture Spheroids

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18421&type=smp

What Key Drivers Are Expected to Influence Future Organoids And Spheroids Market Growth?
The growth of the organoids and spheroids market is anticipated to accelerate due to the increasing demand for cell therapy and tissue engineering. These fields involve using living cells or engineered tissues to repair or regenerate damaged organs and tissues, offering solutions for conditions that were previously untreatable. Organoids and spheroids are used for modeling tissues and testing therapeutic methods. For example, in February 2023, Cell & Gene reported that 27 FDA-approved cell and gene therapies (CGTs) were available, up from 22 in 2021, contributing to the market's growth.

Which Companies Hold the Largest Share Across Different Organoids And Spheroids Market Segments?
Major companies operating in the organoids and spheroids market are Thermo Fisher Scientific Inc., Merck KGaA, Corning Incorporated, Lonza Group AG, StemCell Technologies Canada Inc., Greiner Bio-One International AG, Promega Corporation, Molecular Devices LLC, American Type Culture Collection (ATCC), Mimetas B.V., InSphero AG, HUB Organoids, Emulate Inc., 3D Biomatrix Inc., Prellis Biologics Inc., 3D Biotek LLC, DefiniGEN Limited, Visikol Inc., Organovo Holdings Inc., Cellesce Ltd., AMS Biotechnology (Europe) Limited

What Are the Latest Developing Trends in the Organoids And Spheroids Market?
In the organoids and spheroids market, companies are developing advanced tools like single-particle dispensers to improve research precision and reproducibility. For instance, in July 2024, Switzerland-based SEED Biosciences introduced Dispen3D, a device that automates the precise dispensing of individual organoids or spheroids into multi-well plates. It operates at low pressures to preserve cell integrity and is designed for ease of use across diverse research environments.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/organoids-and-spheroids-global-market-report

What Are the Emerging Geographies for The Organoids And Spheroids Market Growth?
North America was the largest region in the organoids and spheroids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the organoids and spheroids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Organoids And Spheroids Market?
2. What is the CAGR expected in the Organoids And Spheroids Market?
3. What Are the Key Innovations Transforming the Organoids And Spheroids Industry?
4. Which Region Is Leading the Organoids And Spheroids Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Evolving Market Trends In The Organoids And Spheroids Industry: Innovative Single-Particle Dispensers Drive Precision And Efficiency In Drug Discovery here

News-ID: 4041433 • Views:

More Releases from The Business Research Company

Market Trend Insights: The Impact of Emerging Developments on the Insurance Busi …
The insurance business process outsourcing industry is gaining significant traction as companies seek more efficient ways to manage insurance operations. With evolving technologies and a growing number of insurers, this market is set for considerable expansion in the coming years. Let's explore the current market valuation, key players, emerging trends, and segmentation details shaping this sector. Projected Growth and Market Size of the Insurance Business Process Outsourcing Market The insurance
Trends in Growth, Segment Analysis, and Competitive Approaches Influencing the M …
The marine insurance sector is set to undergo significant expansion in the coming years, driven by technological advancements and evolving global risks. This market is adapting to new challenges and opportunities, reflecting shifts in maritime operations and increasing demands for specialized coverage. Here is an in-depth look at the marine insurance market's size, key players, emerging trends, and the main segments fueling its growth. Projected Expansion and Market Size of Marine
Analysis of Key Market Segments Driving the Syndicated Loans Market
The syndicated loans market is poised for substantial expansion in the coming years, driven by a combination of financial trends, investor preferences, and global economic factors. This report explores the projected market size, leading players, notable trends, and segmentation to provide a comprehensive overview of this evolving sector. Expected Market Size and Growth Trajectory of the Syndicated Loans Market The syndicated loans market is anticipated to experience rapid growth, reaching
Market Trend Analysis: The Impact of Emerging Developments on the Remittance Mar …
The digital remittance sector is set for remarkable expansion in the coming years, driven by technological innovations and evolving financial regulations. As cross-border money transfers become more seamless and secure, the industry is positioning itself for impressive growth. Let's explore the projected market size, key players, prevailing trends, and detailed market segments shaping this fast-evolving domain. Forecasted Market Size and Growth of the Digital Remittance Market The digital remittance market

All 5 Releases


More Releases for Organoids

Biocomputer Based on Organoids Market Poised for 16.3% CAGR Driven by Brain Orga …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biocomputer Based on Organoids Market Size, Share & Trends Analysis Report By Organoid Type (Brain Organoids, Other Organoids), Application (Biological Computing, Neuroscience Research, Drug Discovery and Testing, Personalized Medicine, Regenerative Medicine), Technology (Microfluidic Systems Microelectrode Arrays (MEAs), Brain-Machine Interfaces, CRISPR and Gene Editing), End-User (Academic and Research Institutes, Biotechnology and Pharmaceutical Companies, Technology Companies, Contract
Organoids: A Guide to Understanding the Process
Organoids are emerging as a powerful asset for researchers and drug developers as they seek more efficient and accurate methods to identify promising drug candidates and predict their efficacy. The ability to generate patient-derived organoids (PDOs) opens up exciting possibilities for personalized drug screening. Organoids serve as realistic and relevant models for drug screening compared to traditional 2D cell cultures. They mimic the complexity of human organs, including their cellular
Patient-derived organoids open doors to personalized medicine
Recent advances in organoid technology have opened the possibility of revolutionizing basic research, drug discovery and development, and patient treatment. Scientists are exploring the feasibility of using patient-derived organoids (PDOs) to develop and test personalized and regenerative medicine for certain cancer subtypes. Although this shows promise, broad adoption of organoids in drug discovery studies still faces many challenges, such as inconsistent quality, poor yield, slow data acquisition, and inaccurate data processing. We
Organoids Market - Pioneering Solutions for Personalized Medicine: Organoids Sha …
Newark, New Castle, USA - new report, titled Organoids Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Organoids market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Organoids market. The report offers an overview of the market, which briefly describes the
Organoids and Spheroids Market Emerging Trends 2023-2030
The worldwide organoids and spheroids market size was estimated at USD 405.3 million in 2021 and is supposed to develop yearly from 2022 to 2028. Utilization of the organoids and spheroids models to uncover what the COVID-19 infection means for a few digestive cells is supposed to drive the reception of organoids in research. Researchers have been involving these frameworks for testing and recognizable proof of promising prescriptions. Organizations take
Sweden Organoids Market Scrutinized in New Research 2030
Organoids Market: Introduction According to the report, the global organoids market was valued over US$ 1.7 Bn in 2019 and is projected to expand at a high CAGR from 2020 to 2030. Organoids are replicated or miniaturized versions of organs such as stomach, liver, lung, kidney, and brain produced from stems cells in vitro. These miniature models are three-dimensional tissue culture derived from stem cells. The stem cells are derived from pluripotent and